Breast cancer risk in young women in the national breast screening programme:: implications for applying NICE guidelines for additional screening and chemoprevention.

D Gareth Evans; Adam R Brentnall; Michelle Harvie; Sarah Dawe; Jamie C Sergeant; Paula Stavrinos; Susan Astley; Mary Wilson; John Ainsworth; Jack Cuzick; Iain Buchan; Louise S Gorman; Anthony Howell

doi:10.1158/1940-6207.CAPR-14-0037

Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention.

D Gareth Evans, Adam R Brentnall, Michelle Harvie, Sarah Dawe, Jamie C Sergeant, Paula Stavrinos, Susan Astley, Mary Wilson, John Ainsworth, Jack Cuzick, Iain Buchan, Louise S Gorman, Anthony Howell

Research output: Contribution to journal › Article › peer-review

Abstract

In the United Kingdom, women at moderate and high risk of breast cancer between the ages of 40 and 49 years are eligible for annual mammographic screening and preventive therapy with tamoxifen. Here, we estimate the numbers of women in a population eligible for this service and the proportion of breast cancers detected in this group compared with the whole population. Women

Original language	English
Pages (from-to)	993-1001
Number of pages	9
Journal	Cancer Prevention Research
Volume	7
Issue number	10
DOIs	https://doi.org/10.1158/1940-6207.CAPR-14-0037
Publication status	Published - Oct 2014

Keywords

Breast cancer
Risk
Screening
Risk Model
NICE

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1940-6207.CAPR-14-0037

http://cancerpreventionresearch.aacrjournals.org/content/7/10/993.full.pdf+html

Cite this

Evans, D. G., Brentnall, A. R., Harvie, M., Dawe, S., Sergeant, J. C., Stavrinos, P., Astley, S., Wilson, M., Ainsworth, J., Cuzick, J., Buchan, I., Gorman, L. S., & Howell, A. (2014). Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention. . Cancer Prevention Research, 7(10), 993-1001. https://doi.org/10.1158/1940-6207.CAPR-14-0037

@article{ff65e5694f8e4f2f815852f718b196c7,

title = "Breast cancer risk in young women in the national breast screening programme:: implications for applying NICE guidelines for additional screening and chemoprevention. ",

abstract = "In the United Kingdom, women at moderate and high risk of breast cancer between the ages of 40 and 49 years are eligible for annual mammographic screening and preventive therapy with tamoxifen. Here, we estimate the numbers of women in a population eligible for this service and the proportion of breast cancers detected in this group compared with the whole population. Women",

keywords = "Breast cancer, Risk, Screening, Risk Model, NICE",

author = "Evans, {D Gareth} and Brentnall, {Adam R} and Michelle Harvie and Sarah Dawe and Sergeant, {Jamie C} and Paula Stavrinos and Susan Astley and Mary Wilson and John Ainsworth and Jack Cuzick and Iain Buchan and Gorman, {Louise S} and Anthony Howell",

note = "MR/K006665/1, Medical Research Council, United Kingdom",

year = "2014",

month = oct,

doi = "10.1158/1940-6207.CAPR-14-0037",

language = "English",

volume = "7",

pages = "993--1001",

journal = "Cancer Prevention Research",

issn = "1940-6207",

publisher = "American Association for Cancer Research",

number = "10",

}

Evans, DG, Brentnall, AR, Harvie, M, Dawe, S, Sergeant, JC, Stavrinos, P, Astley, S, Wilson, M, Ainsworth, J, Cuzick, J, Buchan, I , Gorman, LS & Howell, A 2014, 'Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention. ', Cancer Prevention Research, vol. 7, no. 10, pp. 993-1001. https://doi.org/10.1158/1940-6207.CAPR-14-0037

TY - JOUR

T1 - Breast cancer risk in young women in the national breast screening programme:

T2 - implications for applying NICE guidelines for additional screening and chemoprevention.

AU - Evans, D Gareth

AU - Brentnall, Adam R

AU - Harvie, Michelle

AU - Dawe, Sarah

AU - Sergeant, Jamie C

AU - Stavrinos, Paula

AU - Astley, Susan

AU - Wilson, Mary

AU - Ainsworth, John

AU - Cuzick, Jack

AU - Buchan, Iain

AU - Gorman, Louise S

AU - Howell, Anthony

N1 - MR/K006665/1, Medical Research Council, United Kingdom

PY - 2014/10

Y1 - 2014/10

N2 - In the United Kingdom, women at moderate and high risk of breast cancer between the ages of 40 and 49 years are eligible for annual mammographic screening and preventive therapy with tamoxifen. Here, we estimate the numbers of women in a population eligible for this service and the proportion of breast cancers detected in this group compared with the whole population. Women

AB - In the United Kingdom, women at moderate and high risk of breast cancer between the ages of 40 and 49 years are eligible for annual mammographic screening and preventive therapy with tamoxifen. Here, we estimate the numbers of women in a population eligible for this service and the proportion of breast cancers detected in this group compared with the whole population. Women

KW - Breast cancer

KW - Risk

KW - Screening

KW - Risk Model

KW - NICE

U2 - 10.1158/1940-6207.CAPR-14-0037

DO - 10.1158/1940-6207.CAPR-14-0037

M3 - Article

C2 - 25047362

SN - 1940-6207

VL - 7

SP - 993

EP - 1001

JO - Cancer Prevention Research

JF - Cancer Prevention Research

IS - 10